alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Commission Implementing Regulation (EU) No 888/2013Show full title

Commission Implementing Regulation (EU) No 888/2013 of 16 September 2013 entering a name in the register of protected designations            of origin and protected geographical indications (Oignon de Roscoff (PDO))         

        - Previous
        - Next

U.K.

# Commission Implementing Regulation (EU) No 888/2013                     

# of 16 September 2013

# entering a name in the register of protected designations of origin and protected geographical indications (Oignon de Roscoff                        (PDO))                     

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 1151/2012 of the European Parliament and of the Council of 21 November 2012 on quality                           schemes for agricultural products and foodstuffs(1), and in particular Article 52(2) thereof,                        

Whereas:

(1)Regulation (EU) No 1151/2012 repealed and replaced Council Regulation (EC) No 510/2006 of 20 March 2006 on the protection                              of geographical indications and designations of origin for agricultural products and foodstuffs(2).

(2)Pursuant to Article 6(2) of Regulation (EC) No 510/2006, France’s application to register the name ‘Oignon de Roscoff’ was                              published in the *Official Journal of the European Union* (3).

(3)As no statement of objection under Article 7 of Regulation (EC) No 510/2006 has been received by the Commission, the name                              ‘Oignon de Roscoff’ should therefore be entered in the register,

HAS ADOPTED THIS REGULATION:

# Article 1U.K.

The name contained in the Annex to this Regulation is hereby entered in the register.

# Article 2U.K.

This Regulation shall enter into force on the twentieth day following that of its publication in the *Official Journal of the European Union*.                  

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 16 September 2013.

*For the Commission, On behalf of the President*,                           

Dacian Cioloș                            

*Member of the Commission*                            

## ANNEXU.K.

Agricultural products intended for human consumption listed in Annex I to the Treaty:

### **Class 1.6.****Fruit, vegetables and cereals, fresh or processed**U.K.

#### FRANCEU.K.

Oignon de Roscoff (PDO)

1

OJ L 343, 14.12.2012, p. 1.                           

2

OJ L 93, 31.3.2006, p. 12.                           

3

OJ C 334, 31.10.2012, p. 11.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Treasury

# DATES:

Written comments should be received on or before October 3, 2005 to be assured of consideration. 

## United States Mint 

*OMB Number:*                     1525-0013.                

*Type of Review:*                     Extension.                

*Title:*                     Application for Commercial Product License and Application for Intellectual Property Use.                

*Form:*                     U.S. Mint form 3044 and form 3045.                

*Description:*                     The application forms allow individuals and business entities to apply for Non-product License or Commercial Product License to use United States Mint intellectual property and trademark and copyright materials for products.                 

*Respondents:*                     Business and other for-profit and individuals or households.                

*Estimated Number of Respondents:*                     120.                

*Estimated Total Reporting Burden:*                     131 hours.                

*Clearance Officer:*                     Yvonne Pollard, (202) 722-7310, United States Mint, 799 9th Street, NW., 4th Floor, Washington, DC 20220.                 

*OMB Reviewer:*                     Alexander T. Hunt, (202) 395-7316, Office of Management and Budget, Room 10235, New Executive Office Building, Washington, DC 20503.                 

Michael A. Robinson, 

Treasury PRA Clearance Officer. 

[FR Doc. 05-17422 Filed 8-31-05; 8:45 am] 

BILLING CODE 4810-37-P
[Federal Register Volume 70, Number 168 (Wednesday, August 31, 2005)]
[Notices]
[Page 51829]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-17256]



[[Page 51829]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the President's Cancer Panel.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as 
amended, because the premature disclosure of information and the 
discussions would be likely to significantly frustrate implementation 
of recommendations.

    Name of Committee: President's Cancer Panel
    Date: September 2, 2005
    Time: 1 p.m. to 4 p.m.
    Agenda: The Panel will discuss and plan the next series of 
meetings in 2005-2006.
    Place: National Cancer Institute, National Institutes of Health, 
6116 Executive Boulevard, Suite 212, Bethesda, MD 20892 
(Teleconference)
    Contact Person: Abby Sandler, Ph.D., Executive Secretary, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Boulevard, Suite 212, Bethesda, MD, 20892, 301/451-9399.
    This meeting is being published less than 15 days prior to the 
meeting due to scheduling conflicts.
    Any interested person may file written comments with the 
committee by forwarding the comments to the Contact Person listed on 
this Notice. The comments should include the name, address, 
telephone number and, when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: deainfo.nci.nih.gov/advisory/pcp/pcp.htm, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 22, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-17256 Filed 8-30-05; 8:45 am]
BILLING CODE 4140-01-M
STATE v. Joseph Marion HEAD, Jr.

No. 629P04-4.

Supreme Court of North Carolina.

August 23, 2007.

Robert Montgomery, Special Deputy Attorney General, Jeff Hunt, District Attorney, for State of NC.

The following order has been entered on the motion filed on the 15th day of June 2007 by Defendant for Relief:

"Motion Denied by order of the Court in conference this the 23rd day of August 2007."
DEPARTMENT OF TRANSP. v. JAMESTOWN VILLAGE ASSOCIATES, LLC.

No. COA07-381.

Court of Appeals of North Carolina.

Filed January 15, 2008.

Certification Date February 4, 2008.

Appeal from Guilford (05CVS4161).

Case reported without published opinion. Dismissed and remanded.
Exhibit 23.1








Consent of Independent Registered Public Accounting Firm





We consent to the incorporation by reference in the registration statements of NovaDel Pharma Inc. on previously filed Forms S-8 (File Nos. 333-167699, 333-148130, 333-42103 and 333-116665) and Forms S-3/S-3A (File Nos. 333-155345, 333-140054, 333-126489, 333-159485, 333-135902, 333-151961 and 333-134028) of our report dated March 29, 2011 on our audits of the balance sheets of NovaDel Pharma Inc. as of December 31, 2010 and 2009 and the related statements of operations, changes in stockholders’ equity (deficiency) and cash flows for each of the three years in the period ended December 31, 2010, which report includes an explanatory paragraph relating to NovaDel Pharma Inc.’s ability to continue as a going concern and  is included in this Annual Report on Form 10-K.








/s/  J.H. Cohn LLP



Roseland, New Jersey

March 29, 2011
WHITLEY v. WOODWORKS.

No. COA07-758.

Court of Appeals of North Carolina.

Filed January 15, 2008.

Certification Date February 4, 2008.

Appeal from NC Industrial Commission (I.C. NO. 428287).

Case reported without published opinion. Affirmed.
11TH COURT OF APPEALS

EASTLAND, TEXAS

JUDGMENT

Henry Krahn Hildebrandt, * From the 106th District Court

of Gaines County,

Trial Court No. 17-4802.

Vs. No. 11-22-00004-CR * January 11, 2024

The State of Texas, * Memorandum Opinion by Bailey, C.J.

(Panel consists of: Bailey, C.J.,

Trotter, J., and Williams, J.)

This court has inspected the record in this cause and concludes that there is no 

error in the judgment below. Therefore, in accordance with this court’s opinion, 

the judgment of the trial court is in all things affirmed.
<TABLE> <S> <C>

<ARTICLE>                                5

<S>                                            <C>
<PERIOD-TYPE>                                        YEAR
<FISCAL-YEAR-END>                             DEC-31-1999
<PERIOD-START>                                JAN-01-1999
<PERIOD-END>                                  DEC-31-1999
<CASH>                                            714,109
<SECURITIES>                                      833,344
<RECEIVABLES>                                   1,103,913
<ALLOWANCES>                                       89,000
<INVENTORY>                                       570,594
<CURRENT-ASSETS>                                3,780,882
<PP&E>                                          4,283,167
<DEPRECIATION>                                  1,735,684
<TOTAL-ASSETS>                                  6,798,612
<CURRENT-LIABILITIES>                             680,998
<BONDS>                                                 0
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                     1,060,000
<COMMON>                                            4,094
<OTHER-SE>                                      5,053,520
<TOTAL-LIABILITY-AND-EQUITY>                    6,798,612
<SALES>                                         5,247,683
<TOTAL-REVENUES>                                5,247,683
<CGS>                                           2,298,923
<TOTAL-COSTS>                                   6,751,130
<OTHER-EXPENSES>                                  352,531
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                 18,594
<INCOME-PRETAX>                                (1,746,583)
<INCOME-TAX>                                      (69,000)
<INCOME-CONTINUING>                            (1,677,583)
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                   (1,677,583)
<EPS-BASIC>                                         (0.59)
<EPS-DILUTED>                                       (0.59)


</TABLE>
STATE v. SHUMATE.

No. COA06-1450.

Court of Appeals of North Carolina.

Filed October 2, 2007.

Certification Date October 22, 2007.

Appeal from Wilkes (05CRS52797).

Case Reported Without Published Opinion. No error.
##### 



Exhibit 12.1 EOP Operating Limited Partnership
Statement of Earnings to Fixed Charges
(Dollars in thousands) For the years ended December 31,2004
    
    
    2003
    
    
    2002
    
    
    2001
    
    
    2000Income before income taxes, allocation to minority interests, income from
investments in unconsolidated joint ventures and gain on sale of real estate
    
    $
    108,243
    
    
    $
    429,493
    
    
    $
    632,032
    
    
    $
    482,547
    
    
    $
    419,821Plus Fixed Charges:Interest expense
    
    
    835,385
    
    
    
    819,730
    
    
    
    809,033
    
    
    
    727,253
    
    
    
    521,746Capitalized interest
    
    
    4,648
    
    
    
    10,089
    
    
    
    20,466
    
    
    
    23,537
    
    
    
    14,277Loan amortization cost
    
    
    15,337
    
    
    
    6,976
    
    
    
    4,964
    
    
    
    15,170
    
    
    
    11,344Fixed charges
    
    
    855,370
    
    
    
    836,795
    
    
    
    834,463
    
    
    
    765,960
    
    
    
    547,367Plus amortization of capitalized interest
    
    
    2,708
    
    
    
    2,043
    
    
    
    1,636
    
    
    
    1,226
    
    
    
    1,026Plus distributed income of investments in unconsolidated joint ventures
    
    
    66,829
    
    
    
    87,624
    
    
    
    149,224
    
    
    
    82,409
    
    
    
    63,942Less capitalized interest
    
    
    (4,648
    )
    
    
    (10,089
    )
    
    
    (20,466
    )
    
    
    (23,537
    )
    
    
    (14,277
    )Less minority interest in pretax income of subsidiaries that have not incurred
fixed charges
    
    
    (3,954
    )
    
    
    (2,193
    )
    
    
    (2,345
    )
    
    
    (2,333
    )
    
    
    (768
    )Total
    
    
    60,935
    
    
    
    77,385
    
    
    
    128,049
    
    
    
    57,765
    
    
    
    49,923Earnings
    
    $
    1,024,548
    
    
    $
    1,343,673
    
    
    $
    1,594,544
    
    
    $
    1,306,272
    
    
    $
    1,017,111Fixed charges
    
    $
    855,370
    
    
    $
    836,795
    
    
    $
    834,463
    
    
    $
    765,960
    
    
    $
    547,367Earnings to fixed charges
    
    
    1.2
    
    
    
    1.6
    
    
    
    1.9
    
    
    
    1.7
    
    
    
    1.9
<PAGE>

 CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICERS
                PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT


                                   Exhibit 32

                           CERTIFICATIONS PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
                            (18 U.S.C. SECTION 1350)

In connection with the Annual Report of Mailkey Corporation, a Nevada
corporation (the "Company"), on Form 10-KSB for the period ended March 31, 2005,
as filed with the Securities and Exchange Commission (the "Report"), Ivan Zweig,
Chief Executive Officer of the Company and Tim Dean-Smith, Chief Financial
Officer of the Company, do hereby certify, pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002 (18 U.S.C. ss. 1350), that to their knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.

/s/ Ivan Zweig
-------------------------
By: Ivan Zweig
Its:  Chief Executive Officer, Director
June 29, 2005

/s/ Tim Dean-Smith
-------------------------
By: Tim Dean-Smith
Its:  Chief Financial Officer, Director
June 29, 2005


[A signed original of this written statement required by Section 906 has been
provided to Mailkey Corporation and will be retained by Mailkey Corporation and
furnished to the Securities and Exchange Commission or its staff upon request.]
**Exhibit 32.1**

 

Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 

(18 U.S.C. 1350) 

 

In connection with the Transition Report of NovaDel Pharma Inc., a Delaware corporation (the “Company”), on Form 10-K for the five-month transition period ended December 31, 2006, as filed with the Securities and Exchange Commission (the “Report”), Jan H. Egberts, M.D., President and Chief Executive Officer of the Company, and Michael E. Spicer, Principal Financial Officer of the Company, respectively, do each hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. ss. 1350), that to his knowledge: 

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

 

| Date:  March 26, 2007 | By:    | /s/ JAN H. EGBERTS                    |
|-----------------------|--------|---------------------------------------|
|                  |   | Jan H. Egberts, M.D.                  |
|                  |   | President and Chief Executive Officer |
|                  |   |                                  |
| Date:  March 26, 2007 | By:    | /s/ MICHAEL E. SPICER                 |
|                  |   | Michael E. Spicer                     |
|                  |   | Chief Financial Officer               |

 

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. 

 

This certification shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Securities Exchange Act.
STATE v. ROSS.

No. COA07-358.

Court of Appeals of North Carolina.

Filed January 15, 2008.

Certification Date February 4, 2008.

Appeal from Wake (05CRS117332, 05CRS122348).

Case reported without published opinion. No error.
SOTO v. HATHAWAY.

No. 336P07.

Supreme Court of North Carolina.

October 11, 2007.

Robert Montgomery, Special Deputy Attorney General, for State of NC.

The following order has been entered on the motion filed on the 10th day of July 2007 by Plaintiff for Petition for Plain Error Review Pursuant to N.C.G.S. 7A-28:

"Motion Dismissed by order of the Court in conference this the 11th day of October 2007."
STATE of North Carolina v. Wayne E. WILKERSON.

No. 213P07.

Supreme Court of North Carolina.

August 23, 2007.

Wayne E. Wilkerson, pro se.

Derrick C. Mertz, Assistant Attorney General, Michael Nifong, District Attorney, for State of NC.

*ORDER*

Upon consideration of the petition filed by Defendant on the 2nd day of May 2007 in this matter for a writ of certiorari to review the order of the Superior Court, Durham County, the following order was entered and is hereby certified to the Superior Court of that County:

"Dismissed by order of the Court in conference, this the 23rd day of August 2007."
Michigan Supreme Court Lansing, Michigan

Marilyn Kelly,
Chief Justice

Michael F. Cavanag h

Elizabeth A. Weave r

Maura D. Corriga n Robert P. Young, Jr. Stephen J. Markma n Diane M. Hathaway,

J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk July 15, 2010

0708 

# Order

July 15, 2010

140356 & (54)

PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee,

v SC: 140356 COA: 284830 Saginaw CC: 03-023823-FH TIMOTHY DEMETRIS HOLDEN, Defendant-Appellant.

________________ _______________ __________/

By order of April 28, 2010, this Court de nied the defendant’s motion to exceed the 50-page limit for his applicatio n for leave to appeal and gave the defendant 14 days to submit an application that co nformed to the court rules. On order of the Court, a conforming application having been filed, the application for leave to appeal the November 19, 2009 judgment of the Court of Appeals is considered, and it is DENIED, because we are not persuaded that the questi ons presented should be reviewed by this

Court.

K ELLY , C.J., would grant leave to appeal.
EXHIBIT 32.1

Certification Pursuant to Rule 13a-14(b) or Rule 15d-14(b)

of the Securities Exchange Act of 1934
and 18 U.S.C. Section 1350

I, Vicente Anido, Jr., Ph.D., hereby certify pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange
Act of 1934 and 18 U.S.C. Section 1350, that the Quarterly Report of ISTA Pharmaceuticals, Inc. on Form 10-Q for the quarterly period ended June 30, 2008 fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q for the period ended June 30, 2008 fairly presents in all material respects the financial condition and results of operations of ISTA Pharmaceuticals,
Inc.



|                     |  |  |  |                                      
|-------------------- |  |  |  | -------------------------------------
|                     |  | 
|Date: August 8, 2008 |  |  |  | /s/ Vicente Anido, Jr., Ph.D.        
|                     |  |  |  | Vicente Anido, Jr., Ph.D.            
|                     |  |  |  | President and Chief Executive Officer

This certification accompanies the Quarterly Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the
Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.
BOLDEN v. BARTON

No. S07A0317.

Supreme Court of Georgia.

June 11, 2007.

Judgments Affirmed Without Opinion